Metformin: Perbedaan antara revisi

Jelajahi riwayat secara interaktif

← Revisi sebelumnya Revisi selanjutnya →

Konten dihapus Konten ditambahkan

VisualTeks wiki

Revisi per 29 Juni 2024 09.12 sunting Muhammad Anas Sidik (bicara \| kontrib) 21.510 suntingan Tidak ada ringkasan suntingan Tag: Suntingan perangkat seluler Suntingan peramban seluler Suntingan seluler lanjutan ← Revisi sebelumnya		Revisi per 2 Juli 2024 12.36 sunting balikkan Hysocc (bicara \| kontrib) Pengguna terkonfirmasi, Peninjau 62.004 suntingan k Menghapus Kategori:Obat yang dikembangkan oleh Merck & Co.; Menambah Kategori:Obat yang dikembangkan oleh Merck KGaA menggunakan HotCat Revisi selanjutnya →
(3 revisi perantara oleh 2 pengguna tidak ditampilkan)
Baris 10: <!-- Clinical data --> \| pronounce = {{IPAc-en\|m\|ɛ\|t\|ˈ\|f\|ɔːr\|m\|ᵻ\|n}}, {{respell\|met\|FOR\|min}} \| tradename = Diabit, Forbetes, Glikos, Glucophage, ~~[[#Formulations\|others]]~~Gludepatic, dll \| Drugs.com = {{drugs.com\|monograph\|metformin-hydrochloride}} \| MedlinePlus = a696005 Baris 17: \| pregnancy_AU_comment = <ref name="Drugs.com pregnancy">{{cite web \| title=Metformin Use During Pregnancy \| website=Drugs.com \| date=10 September 2019 \| url=https://www.drugs.com/pregnancy/metformin.html \| access-date=4 February 2020 \| archive-date=16 April 2020 \| archive-url=https://web.archive.org/web/20200416182342/https://www.drugs.com/pregnancy/metformin.html \| url-status=live }}</ref> \| pregnancy_category = \| routes_of_administration = [[Oral ~~administration\|By mouth]]~~ \| class = [[Antidiabetic agent]] \| ATC_prefix = A10 Baris 68: \| bioavailability = 50–60%<ref name = D95>{{cite journal \| vauthors = Dunn CJ, Peters DH \| title = Metformin. A review of its pharmacological properties and therapeutic use in non-insulin-dependent diabetes mellitus \| journal = Drugs \| volume = 49 \| issue = 5 \| pages = 721–49 \| date = May 1995 \| pmid = 7601013 \| doi = 10.2165/00003495-199549050-00007 }}</ref><ref name=D03>{{cite journal \| vauthors = Hundal RS, Inzucchi SE \| title = Metformin: new understandings, new uses \| journal = Drugs \| volume = 63 \| issue = 18 \| pages = 1879–94 \| year = 2003 \| pmid = 12930161 \| doi = 10.2165/00003495-200363180-00001 }}</ref> \| protein_bound = Minimal<ref name = D95 /> \| metabolism = ~~Not~~Bukan bydengan ~~liver~~hati<ref name = D95 /> \| metabolites = \| onset = \| elimination_half-life = 4–8.,7 ~~hours~~jam<ref name = D95 /> \| duration_of_action = \| excretion = ~~Urine~~Urin (90%)<ref name = D95 /> <!-- Identifiers --> Baris 96: \| NIAID_ChemDB = \| PDB_ligand = \| synonyms = ''N'',''N''-~~dimethylbiguanide~~dimetilbiguanida<ref>{{cite journal \| vauthors = Sirtori CR, Franceschini G, Galli-Kienle M, Cighetti G, Galli G, Bondioli A, Conti F \| title = Disposition of metformin (N,N-dimethylbiguanide) in man \| journal = Clinical Pharmacology and Therapeutics \| volume = 24 \| issue = 6 \| pages = 683–93 \| date = December 1978 \| pmid = 710026 \| doi = 10.1002/cpt1978246683 \| s2cid = 24531910 }}</ref> <!-- Chemical and physical data --> \| IUPAC_name = ''N'',''N''-~~Dimethylimidodicarbonimidic~~Dimetilimidodikarbonimidat ~~diamide~~diamida \| C = 4 \| H = 11 \| N = 5 \| SMILES = CN(C)C(=N)N=C(N)N Baris 162: [[Kategori:Biguanid]] [[Kategori:guanidina]] [[Kategori:~~Obat~~Antipenuaan]] [[Kategori:Obat dengan cara kerja yang belum diketahui]] [[Kategori:Obat piatu]] [[Kategori:Obat yang dikembangkan oleh Boehringer Ingelheim]] [[Kategori:Obat yang dikembangkan oleh Merck KGaA]] [[Kategori:Obat Esensial Organisasi Kesehatan Dunia]]